13 Jul Riveria Makes Minority Investment in Yaqrit Discovery Ltd.
London, UK– July 9, 2020 – Riveria Investment Group is pleased to announce a minority investment in Yaqrit Discovery Ltd. as it prepares for an upcoming Initial Public Offering (“IPO”).
About Yaqrit Discovery Ltd:
Yaqrit is a clinical stage liver disease company, spun out of University College London in 2014. The Company’s current developments are based on more than 20 years of researching for liver disease. Their first programs are for severely ill patients – with cirrhosis or Acute-on-Chronic Liver Failure (ACLF). The Company plans to broaden its approach to include patients with complication of cirrhosis, Non-Alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), which affects more than 25% of populations in developed economies.
About Riveria Investment Group:
Riveria Investment Group, headquartered in New York, NY, is a growth focused private equity firm that acquires and invests in middle-market companies based in the United States. Riveria primarily focuses on growing companies with a history of positive operating cash-flows and seeks transactions that present unique investment opportunities in industries experiencing significant growth.Riveria’s private equity efforts emphasize growth and value-added strategies to generate strong returns. Riveria actively engages in the operations of portfolio companies by collaborating with management and implementing executive operating partners to grow its investments. Riveria Investment Group’s website is: www.riveriagroup.com